Cargando…
Evaluation of anti-EGFR-iRGD recombinant protein with GOLD nanoparticles: synergistic effect on antitumor efficiency using optimized deep neural networks
The epidermal growth factor receptor, also known as EGFR, is a tyrosine kinase receptor commonly found in epithelial tumors. As part of the first target for cancer treatment, EGFR has been the subject of intense research for more than 20 years; as a result, there are a number of anti-EGFR agents cur...
Autores principales: | Chandra Kaushik, Aman, Wang, Yan-Jing, Wang, Xiangeng, Kumar, Ajay, Singh, Satya P., Pan, Cheng-Tang, Shiue, Yow-Ling, Wei, Dong-Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065452/ https://www.ncbi.nlm.nih.gov/pubmed/35519377 http://dx.doi.org/10.1039/c9ra01975h |
Ejemplares similares
-
Anti-EGFR-iRGD recombinant protein conjugated silk fibroin nanoparticles for enhanced tumor targeting and antitumor efficiency
por: Bian, Xinyu, et al.
Publicado: (2016) -
Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment
por: Zhang, Zhen, et al.
Publicado: (2018) -
Coupling Gd-DTPA with a bispecific, recombinant protein anti-EGFR-iRGD complex improves tumor targeting in MRI
por: XIN, XIAOYAN, et al.
Publicado: (2016) -
Improved Anticancer Effect of Recombinant Protein izTRAIL Combined with Sorafenib and Peptide iRGD
por: Fadeev, Roman, et al.
Publicado: (2019) -
An iRGD peptide conjugated heparin nanocarrier for gastric cancer therapy
por: Ai, Shichao, et al.
Publicado: (2018)